Haematological Malignancy Clinical Trial
— APALLOOfficial title:
APALLO : Post Allogeneic Stem Cell Transplantation Adapted Physical Activity for Patient With Hematological Malignancies
NCT number | NCT05379738 |
Other study ID # | 21-PP-12 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | June 10, 2022 |
Est. completion date | April 10, 2028 |
It is a study about adaptated physical activity for patients receiving a stem cell transplantation. They will benefit of 6 adaptated individuals lessons at home between 1 month and 3 months after stem cell transplantation. The study's goal is to observe if adaptated activity has an positive impact on weight loss and on life quality.
Status | Recruiting |
Enrollment | 75 |
Est. completion date | April 10, 2028 |
Est. primary completion date | December 10, 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion criteria : - Patient aged 18 or more - Patient with social security - Patient who accept the study and sign the consent form - Patient programmed for an allogenic stem cell transplantation Non inclusion criteria : - Patients with a guardianship - Patients with a significant additional physic or mental disease Exclusion criteria - Patients who did not receive an allogeniac stem cell transplantation - Patients still hospitalized between day 30 and day 100 after stem cell transplantation - Patients who finally refuses the study - Patients who develop a physical or mental incapacity to practice physical activity |
Country | Name | City | State |
---|---|---|---|
France | CHU NICE, hopital ARCHET 1, hématologie | Nice |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire de Nice |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | weight loss | Body weight n in kilograms | before stem cell transplantation, 1 month , 3 months, 1 year after stem cell transplantation | |
Primary | weight loss | Calculation of the percent of body weight loss between the " before stem cell transplantation evaluation " and each evaluation after stem cell transplantation and after adaptated physical activity sessions. | before stem cell transplantation, 1 month , 3 months, 1 year after stem cell transplantation | |
Secondary | patient's ability to attend the classes | number of adaptated physical activity lessons attended by each patient after stem cell transplantation, calculation of feasibility | 3 months after stem cell transplantation | |
Secondary | body mass index | Measure of weight and height to evaluate the nutriotional status of a patient | before stem cell transplantation, 1 month , 3 months, 1 year after stem cell transplantation | |
Secondary | brachial muscle circumference | evaluation in centimeters of the brachial circumference to evaluate the evolution of the muscle circumference after stem cell transplantation and adaptated physical activity compared to the evaluation before stem cell transplantation. Using a measuring tape | before stem cell transplantation , 1 month , 3 months, 1 year after stem cell transplantation | |
Secondary | grip strength evaluation | it is a measure of muscular strength | before stem cell transplantation , 1 month , 3 months, 1 year after stem cell transplantation | |
Secondary | short physical battery test | it is a series of 3 physical tests to evaluate mobility the first test is a balance test (4 points), the second test is an evaluation of a walking speed (4 points) and the third test is a Chair rise test (4 points) The global test is on 12 points (12 is the better score) | before stem cell transplantation , 1 month , 3 months, 1 year after stem cell transplantation | |
Secondary | Quality of Life Questionary C30 (QLQ-C30) | it is a score to evaluate the quality of life of patients facing illness The subscales scores are transformed to a 0 to 100 scale, with higher score on functionnal scales indicating better function and higher scores on sumptom scales indicating worse symptoms | before stem cell transplantation , 1 month , 3 months, 1 year after stem cell transplantation | |
Secondary | in house developped physical activities questionary | it is a questionnary created especially for this study to evaluate on each step the capacity of each patient to maintain physical activities (social activities, autonomy at home for cooking and hygiene care, autonomy for transport to go to hospital appointments) | before stem cell transplantation , 1 month , 3 months, 1 year after stem cell transplantation |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03978312 -
Nutrition Health Literacy of Cancer Patients and Their Support Networks.
|
||
Recruiting |
NCT03750994 -
Economic Evaluation of Innovative Molecular Analyses in Onco-haematology
|
||
Recruiting |
NCT04397705 -
Remote Monitoring of Cancer Patients With Suspected Covid-19
|
Phase 1 | |
Recruiting |
NCT05678621 -
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension
|
Phase 2/Phase 3 | |
Recruiting |
NCT05203809 -
Continuous Temperature Monitoring for tHe Early Recognition of Febrile Neutropenia in Haematological MALignancies
|
||
Active, not recruiting |
NCT03146468 -
Nivolumab for Relapsed or Residual Haematological Malignancies After Allogeneic Stem Cell Transplantation
|
Phase 2 | |
Recruiting |
NCT05298930 -
Feasibility Study to Assess an Adapted Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Transplantation
|
N/A | |
Not yet recruiting |
NCT06395220 -
Kinectics of Donor-specific Anti-HLA Antibody After HLA-incompatible Allogeneic Haematopoietic Stem Cell Transplantation
|
||
Recruiting |
NCT05786716 -
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Teenage/Young Adult and Paediatric Patients With Cancers With HER2 Amplification or Activating Mutations
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT04673305 -
Cognitive Status Assessment In Elderly Patients With Active Treatment For Haematological Malignancies
|
N/A | |
Recruiting |
NCT05768178 -
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.
|
Phase 2/Phase 3 | |
Recruiting |
NCT05722886 -
DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol
|
Phase 2/Phase 3 | |
Completed |
NCT03855969 -
Central Venous Access Device Removal in Cancer Patients
|
||
Recruiting |
NCT04174053 -
Concordance Between 2 Means of Temperature Measure in Neutropenic Patients Hospitalized in Intensive Hematology Care Units
|
N/A | |
Recruiting |
NCT05770544 -
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Teenage/Young Adults and Paediatric Patients With ROS1 Gene Fusion-positive Cancers.
|
Phase 2/Phase 3 | |
Completed |
NCT04236063 -
Rehabilitation Needs of the Malaysian Haematological Cancer Survivors
|
||
Recruiting |
NCT05695638 -
Proseq Cancer: Genomic Profiling in Patients With Incurable Cancer in Search for Targeted Treatment
|
||
Recruiting |
NCT04298892 -
Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies
|
||
Withdrawn |
NCT03688789 -
Hématologie Adulte Prevalence of Adrenal Insufficiency Post-chemotherapy Adrenocorticotropia in Adult Hematology
|
N/A | |
Withdrawn |
NCT04331483 -
A Study to Assess a Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Allografts
|
N/A |